In this episode of the Health Risk Intelligence Brief, we dive deep into the hidden layers of corporate health that traditional dashboards often miss. While many workplace wellbeing strategies focus on visible issues like stress or ergonomics, there is a "long tail" of chronic, invisible risks—such as hypertension, insulin resistance, and autoimmune disorders—that can quietly erode organizational resilience.

We explore why "rare" medically doesn't mean "insignificant" organizationally, noting that while individual rare diseases affect few, they collectively impact 300 million people worldwide. Our discussion covers:

• The Cost of "Silent" Conditions: How undiagnosed cardiovascular and metabolic risks lead to high-cost medical claims and catastrophic health events.
• Shifting the Parad ...